MiRXES’ patented reverse transcription (RT)-quantitative polymerase chain reaction (qPCR) technology platform enables sensitive, specific, and robust detection of microRNAs and other non-coding RNAs in biofluids and tissue samples.
This platform has been independently validated to be more sensitive than other RT-qPCR technologies for microRNA quantification.